Sterling Investment Advisors (Pennsylvania)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Sterling Investment Advisors (Pennsylvania)'s GILD Position: Q2 2026 in Review
Sterling Investment Advisors (Pennsylvania) sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,657 shares — an estimated $231K sold.
Sterling Investment Advisors (Pennsylvania) first reported a position in GILD in Q4 2016 and held it in 21 quarters. The position peaked at $1.2M in Q2 2020. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Sterling Investment Advisors (Pennsylvania) reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
- Sterling Investment Advisors (Pennsylvania) sold 1,657 Gilead Sciences shares in Q2 2026, an estimated $231K.
- Sterling Investment Advisors (Pennsylvania) first reported a position in Gilead Sciences in Q4 2016 and held it in 21 quarters.
- Sterling Investment Advisors (Pennsylvania)'s Gilead Sciences position peaked at $1.2M in Q2 2020.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q2 2026, filed 28 Jul 2026.